A case of HER2-positive male occult breast carcinoma with skin and lymph node metastases that exhibited complete response to trastuzumab monotherapy.
Kouichi KuninakaRyo TakahashiYutaka NakagawaTadashi NishimakiPublished in: Clinical case reports (2017)
Metastatic male occult HER2-positive breast cancer can be successfully treated with trastuzumab monotherapy.